NCT04058145 AMD3100 Plus Pembrolizumab in Immune Checkpoint Blockade Refractory Head and Neck Squamous Cell Carcinoma Status WITHDRAWN Phase PHASE2
NCT01655875 AMD3100 for Sensitizing in Allogeneic Blood or Marrow Transplant for Chemotherapy Resistant Pediatric Acute Leukemia Status TERMINATED Phase PHASE1
NCT01026987 Granulocyte Colony-stimulating Factor (G-CSF) Plus or Minus AMD3100 for Engraftment Post Allogeneic Transplant Status COMPLETED Phase PHASE1
NCT00914849 Intravenous (IV) AMD3100 for Mobilization and Matched Related Transplant for Advanced Hematological Malignancies Status COMPLETED Phase PHASE2
NCT00733824 Intravenous AMD3100 for Collection of Autologous Peripheral Blood Stem Cells in Patients With Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT00512252 AMD3100 Plus Mitoxantrone, Etoposide and Cytarabine in Acute Myeloid Leukemia Status COMPLETED Phase PHASE1/PHASE2
NCT00479115 Mobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and AMD3100 Status COMPLETED Phase PHASE1/PHASE2
NCT00396968 AMD3100 With Busulfan, Fludarabine and Thymoglobulin for Allogeneic Stem Cell Transplant for AML and MDS Status WITHDRAWN Phase PHASE1/PHASE2
NCT00322127 An Evaluation of Safety and Efficacy of Escalating Doses of AMD3100 to Mobilize CD34+ Cells in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT00241358 Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies Status COMPLETED Phase PHASE1/PHASE2